Skip to main content
Equibles
TCRX logo

TCRX · TScan Therapeutics, Inc.

Track TCRX — free

Use TCRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.61 -0.06 (-8.39%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“However, substantial doubt about the Company's ability to continue as a going concern exists. ... These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Therefore, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”
View the 10-Q filed Aug 12, 2026
Market Cap
$51.07M
Shares
67.78M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2024-08-23 ZDRAVESKI ZORAN 164,686
2023-05-15 SOUTHWELL DAVID P 85,911
Showing 1–2 of 2 filings
Key facts CIK 1783328 CUSIP 89854M101 13F (30d) 59 filings 58 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)